Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-01-28

FDA Approved: NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for a combined oral contraceptive containing norethindrone, ethinyl estradiol, and ferrous fumarate, submitted by My…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE (norethindrone, ethinyl estradiol, and ferrous fumarate)

Snippet

SUPPL AP for NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE (NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE)